After analyzing 33 studies with a total population of 2612 individuals (775 controls and 1837 MASLD patients), they found that patients diagnosed with MASLD or metabolic dysfunction-associated steatohepatitis (MASH) have higher levels of leptin in their bloodstream [200]. Here, LEP is linked to metabolic dysfunction-associated steatohepatitis.